Inventor · disambiguated record
Martin Missbach
Also filed as: MISSBACH MARTIN
20 granted patents·11 pending applications·171 citations·filing 1991–2009
94Inventor score
Top patents by PatentIndex Score
31 records- 0191US6353017B1Dipeptide nitrilesNOVARTIS AG·Filed 2000·Granted Mar 5, 2002·52 cites·22 claims
- 0286US6620838B1Benzopyrazone compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM INC·Filed 2002·Granted Sep 16, 2003·24 cites·33 claims
- 0382US6642239B2Dipeptide nitrile cathepsin K inhibitorsNOVARTIS AG·Filed 2001·Granted Nov 4, 2003·12 cites·11 claims
- 0477US7820818B2Heteroaryl nitrile derivativesNOVARTIS AG·Filed 2009·Granted Oct 26, 2010·3 cites·7 claims
- 0572US7247646B2Benzopyranone compounds, compositions thereof, and methods of treatment therewithNOVARTIS AG·Filed 2004·Granted Jul 24, 2007·6 cites·4 claims
- 0670US7452886B2Pyrrolo pyrimidines as agents for the inhibition of cystein proteasesNOVARTIS AG·Filed 2002·Granted Nov 18, 2008·5 cites·7 claims
- 0769US7544688B2Hetereoaryl nitrile derivativesNOVARTIS AG·Filed 2003·Granted Jun 9, 2009·4 cites·11 claims
- 0868US5869485APyrrolo 2,3-d!pyrimidines and their useNOVARTIS FINANCE CORP·Filed 1995·Granted Feb 9, 1999·28 cites·9 claims
- 0961US2007191392A1Dipeptide nitrile cathespin k inhibitorsNOVARTIS AG·Filed 2007·Application pending·0 cites
- 1059US2006235220A1Dipeptide nitrilesMISSBACH MARTIN·Filed 2006·Application pending·0 cites
- 1157US2008027060A1Dipeptide nitrilesALTMANN EVA·Filed 2007·Application pending·0 cites
- 1257US2005267129A1Dipeptide nitrile cathepsin K inhibitorsNOVARTIS AG·Filed 2005·Application pending·0 cites
- 1356US2009054467A1Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein ProteasesBETSCHART CLAUDIA·Filed 2008·Application pending·0 cites
- 1454US2003203919A1Dipeptide nitrile cathepsin K inhibitorsFiled 2003·Application pending·0 cites
- 1552US2007123511A1Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancerSAKATA STEVEN T·Filed 2006·Application pending·0 cites
- 1652US2004110806A1Dipeptide derivativesFiled 2003·Application pending·0 cites
- 1751US5958683AScreening method using the RZR receptor familyNOVARTIS AG·Filed 1995·Granted Sep 28, 1999·9 cites·23 claims
- 1850US5399576AThiazolesCIBA GEIGY CORP·Filed 1994·Granted Mar 21, 1995·3 cites·11 claims
- 1950US5344842AThiosemicarbazone derivativesCIBA GEIGY CORP·Filed 1993·Granted Sep 6, 1994·8 cites·9 claims
- 2050US2004029814A1Dipeptide nitrilesFiled 2003·Application pending·0 cites
- 2149US5641776ASubstituted thiosemicarbazone derivativesCIBA GEIGY CORP·Filed 1994·Granted Jun 24, 1997·3 cites·7 claims
- 2248US2004092572A1Benzopyranone compounds, compositions thereof, and methods of treatment therewithFiled 2003·Application pending·0 cites
- 2342US5627180ASubstituted thiosemicarbazonethionesCIBA GEIGY CORP·Filed 1994·Granted May 6, 1997·4 cites·10 claims
- 2441US5229405AUse of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredientsCIBA GEIGY CORP·Filed 1992·Granted Jul 20, 1993·4 cites·11 claims
- 2540US2007135448A1Use of cathepsin k inhibitors for treating of severe bone loss diseasesMISSBACH MARTIN·Filed 2004·Application pending·0 cites
- 2638US6218359B1Screening method using the RZR receptor familyNOVARTIS AG·Filed 1999·Granted Apr 17, 2001·3 cites·1 claims
- 2738US5177091AUse of carbazones as novel active ingredients in medicamentsCIBA GEIGY CORP·Filed 1991·Granted Jan 5, 1993·3 cites·10 claims
- 2833US5338746AThiosemicarbazonic acid estersCIBA GEIGY CORP·Filed 1993·Granted Aug 16, 1994·0 cites·8 claims
- 2932US5491158AThiosemicarbazonethionesCIBA GEIGY CORP·Filed 1993·Granted Feb 13, 1996·0 cites·10 claims
- 3032US5378719AImidazolesCIBA GEIGY CORP·Filed 1994·Granted Jan 3, 1995·0 cites·8 claims
- 3130US5633253ASubstituted thiosemicarbazonic acid estersCIBA GEIGY CORP·Filed 1994·Granted May 27, 1997·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Martin Missbach files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →